Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Effectiveness and Safety of Palivizumab for the Prevention of Serious Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus: A Systematic Review.
Journal: American journal of perinatology
Published: December 01, 2022
RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020.
Journal: Human vaccines & immunotherapeutics
Published: November 22, 2022
Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data.
Journal: American journal of perinatology
Published: October 27, 2021
Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS).
Journal: The Journal of infectious diseases
Published: April 09, 2020
Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.
Journal: Journal of medical economics
Published: August 22, 2019
Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants.
Journal: Infectious diseases and therapy
Published: August 25, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026